Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Showing 1 - 18 of 18 Results

Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research

Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements

Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)

Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed)

Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations

Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease

Release Date
Expiration Date
Expiration Date
Type of Award
Clinical Trials
Archived
Yes

Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening

Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States

Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research

Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)

Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

Identifying Innovative Mechanisms or Interventions That Target Multimorbidity and its Consequences (R01 Clinical Trial Optional)